Biotage resolves upon a rights issue
On September 12, 2005 the board of Biotage AB resolved, based on the authorization to the board by the extraordinary shareholders’ meeting held on August 30, 2005, to increase the company’s share capital by not more than SEK 8,044,212 through an issue of not more than 8,044,212 new ordinary shares, or such higher amount or such higher number of shares that may come from exercise of warrants entitling to subscription of shares. The issue is to be executed with preferential rights for the shareholders. The record day for receiving subscription rights shall be October 31, 2005. Each existing